Evidence map›Paper›PMID 25924610›Full record

ArticleBMC research notes2015

Transcriptional profiling of PRKG2-null growth plate identifies putative down-stream targets of PRKG2.

James E Koltes, Dinesh Kumar, Ranjit S Kataria, Vickie Cooper, James M Reecy

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Case Report: Dual pathogenic mechanism of aFrontiers in genetics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genes · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

James E KoltesDepartment of Animal Science, Iowa State University, 2255 Kildee Hall, Ames, IA, 50011, USA. jekoltes@iastate.edu.
Dinesh KumarNational Bureau of Animal Genetic Resources, Karnal, 132001, Haryana, India. dineshkumarbhu@gmail.com.
Ranjit S KatariaNational Bureau of Animal Genetic Resources, Karnal, 132001, Haryana, India. katariaranji@yahoo.co.in.
Vickie CooperVeterinary Diagnostics and Production Animal Medicine, Iowa State University College of Veterinary Medicine, Ames, IA, 50011-3150, USA. vcooper@iastate.edu.
James M ReecyDepartment of Animal Science, Iowa State University, 2255 Kildee Hall, Ames, IA, 50011, USA. jreecy@iastate.edu.
Iowa State University · USIndian Agricultural Statistics Research Institute · INNational Bureau of Animal Genetic Resources · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKinase activity of cGMP-dependent, type II, protein kinase (PRKG2) is required for the proliferative to hypertrophic transition of growth plate chondrocytes during endochondral ossification. Loss of PRKG2 function in rodent and bovine models results in dwarfism. The objective of this study was to identify pathways regulated or impacted by PRKG2 loss of function that may be responsible for disproportionate dwarfism at the molecular level.

methodsMicroarray technology was used to compare growth plate cartilage gene expression in dwarf versus unaffected Angus cattle to identify putative downstream targets of PRGK2.

resultsPathway enrichment of 1284 transcripts (nominal p < 0.05) was used to identify candidate pathways consistent with the molecular phenotype of disproportionate dwarfism. Analysis with the DAVID pathway suite identified differentially expressed genes that clustered in the MHC, cytochrome B, WNT, and Muc1 pathways. A second analysis with pathway studio software identified differentially expressed genes in a host of pathways (e.g. CREB1, P21, CTNNB1, EGFR, EP300, JUN, P53, RHOA, and SRC). As a proof of concept, we validated the differential expression of five genes regulated by P53, including CEBPA, BRCA1, BUB1, CD58, and VDR by real-time PCR (p < 0.05).

conclusionsKnown and novel targets of PRKG2 were identified as enriched pathways in this study. This study indicates that loss of PRKG2 function results in differential expression of P53 regulated genes as well as additional pathways consistent with increased proliferation and apoptosis in the growth plate due to achondroplastic dwarfism.

Indexed as

Gene Expression ProfilingTranscription, GeneticAnimalsApoptosisCattleCell CycleCyclic GMP-Dependent Protein Kinase Type IIGene OntologyGrowth PlateReal-Time Polymerase Chain ReactionReproducibility of ResultsSoftwareTumor Suppressor Protein p53Cyclic GMP-Dependent Protein Kinase Type IITumor Suppressor Protein p53

Identifiers

PMID25924610
PMCPMC4419418
OpenAlexW2013288197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.